Description
CJC-1295 + Ipamorelin Blend combines two extensively studied research peptides that influence complementary signaling pathways involved in growth hormone regulation. CJC-1295 is a synthetic analog of growth hormone-releasing hormone (GHRH) engineered to exhibit prolonged biological stability, while Ipamorelin is a selective ghrelin receptor agonist recognized for its receptor specificity within experimental endocrine models.
The combination has become a widely referenced research tool because it enables scientists to investigate simultaneous activation of GHRH and ghrelin receptor pathways. Rather than examining each signaling mechanism independently, researchers can evaluate receptor cross-talk, coordinated intracellular signaling, endocrine regulation, and downstream molecular responses within controlled laboratory environments.
At Appex Peptide Lab, every batch of CJC-1295 + Ipamorelin Blend is synthesized using stringent manufacturing standards and undergoes comprehensive analytical verification to ensure purity, identity, and reproducibility. The stable lyophilized formulation supports long-term laboratory storage and consistent experimental performance across multiple research applications.
Universities, biotechnology companies, pharmaceutical organizations, and life science laboratories throughout the United States, Canada, and Australia rely on this research-grade peptide blend for advanced studies involving peptide pharmacology, receptor biology, endocrine physiology, and growth hormone signaling networks.
Key Research Highlights
- Premium research-grade peptide blend
- Combines CJC-1295 DAC and Ipamorelin
- High-purity lyophilized formulation
- Third-party laboratory tested
- HPLC purity verification
- Certificate of Analysis (COA) available
- Batch-tested for consistency
- Suitable for GHRH and ghrelin receptor research
- Designed for endocrine signaling investigations
- Stable formulation for laboratory applications
- Secure packaging for research environments
- Fast shipping to the USA, Canada, and Australia
Why Researchers Choose This Product
Researchers investigating endocrine signaling require peptide preparations with exceptional analytical quality and reproducible performance.
Researchers choose this blend because it offers:
- High analytical purity
- Verified identity of both peptide components
- Excellent batch-to-batch consistency
- Independent third-party laboratory testing
- Stable lyophilized formulation
- Comprehensive analytical documentation
- Reliable peptide ratio verification
- Research-grade manufacturing standards
- Trusted by endocrinology and physiology laboratories
- Optimized for advanced receptor signaling studies
Research Applications
Growth Hormone-Releasing Hormone Research
Studies investigating GHRH receptor activation, ligand binding, and intracellular signaling associated with pituitary endocrine function.
Ghrelin Receptor Biology
Experimental investigations involving selective activation of the growth hormone secretagogue receptor (GHSR-1a), receptor pharmacology, and signal transduction.
Neuroendocrine Signaling
Research examining communication between hypothalamic and pituitary signaling pathways and peptide-mediated endocrine regulation.
IGF-1 Regulatory Pathways
Laboratory studies exploring downstream molecular pathways associated with growth hormone signaling and insulin-like growth factor regulation.
Peptide Pharmacology
Research involving receptor affinity, ligand specificity, peptide stability, and structure-activity relationships.
Molecular Endocrinology
Experimental investigations evaluating intracellular signaling cascades, transcriptional responses, and endocrine communication networks.
Cell-Based Assays
Suitable for in vitro receptor activation studies, peptide characterization, and downstream signaling analysis.
Peptide Combination Research
Laboratory investigations assessing coordinated peptide activity, receptor cross-talk, and synergistic signaling mechanisms.
Product Specifications
| Specification | Details |
|---|---|
| Product Name | CJC-1295 + Ipamorelin Blend |
| Available Strength | 10 mg Blend |
| Composition | CJC-1295 DAC + Ipamorelin |
| Purity | ≥98% each peptide (HPLC Verified) |
| Peptide Type | Synthetic GHRH Analog + Selective Ghrelin Receptor Agonist |
| Molecular Formula | Blend of two synthetic peptides |
| Molecular Weight | CJC-1295 DAC: ~3,649 Da; Ipamorelin: ~711.9 Da |
| CAS Number | CJC-1295: 863288-34-0; Ipamorelin: 170851-70-4 |
| Appearance | White to off-white lyophilized powder |
| Solubility | Soluble in appropriate laboratory-grade aqueous research solvents |
| Storage Conditions | Store unopened at -20°C. Protect from moisture, direct light, excessive heat, and repeated freeze-thaw cycles. |
| Sequence | CJC-1295 DAC: Modified 29-amino-acid GHRH analog with maleimidopropionyl group. Ipamorelin: Aib-His-D-2-Nal-D-Phe-Lys-NH₂ |
Mechanism of Action
Within laboratory research, CJC-1295 + Ipamorelin Blend is investigated for its coordinated activation of two distinct endocrine signaling pathways that regulate growth hormone physiology. Each peptide interacts with a different receptor system, allowing researchers to study complementary molecular mechanisms within a single experimental model.
CJC-1295 functions as a synthetic analog of growth hormone-releasing hormone (GHRH) and binds to the growth hormone-releasing hormone receptor (GHRHR) located on pituitary somatotroph cells. Activation of this receptor stimulates adenylate cyclase, elevates intracellular cyclic adenosine monophosphate (cAMP), activates protein kinase A (PKA), and initiates downstream transcriptional signaling associated with endocrine regulation. The addition of a Drug Affinity Complex (DAC) enables reversible albumin binding, increasing molecular stability and prolonging receptor interaction in laboratory systems.
Ipamorelin selectively targets the growth hormone secretagogue receptor (GHSR-1a), a G protein-coupled receptor activated through ghrelin-mediated signaling. Experimental studies investigate how receptor activation influences phospholipase C (PLC), intracellular calcium mobilization, protein kinase C (PKC), and mitogen-activated protein kinase (MAPK) signaling pathways. Because Ipamorelin demonstrates high receptor selectivity in laboratory models, it is frequently used to examine ghrelin receptor pharmacology and intracellular signaling dynamics.
When studied together, the blend enables researchers to evaluate receptor cross-talk between GHRHR and GHSR-1a, coordinated intracellular signaling, endocrine network regulation, and downstream pathways associated with growth hormone and insulin-like growth factor (IGF-1) signaling. Scientific investigations also explore peptide synergy, receptor sensitivity, transcriptional responses, and peptide pharmacodynamics within controlled experimental environments.
The complementary pharmacological characteristics of both peptides make this blend a valuable research tool for molecular endocrinology, receptor biology, peptide chemistry, and cellular signaling investigations. All studies involving this product are intended exclusively for laboratory research.
For research use only. Not intended for human consumption or clinical use.





Reviews
There are no reviews yet.